MARKET CURRENTS
real-time news and commentary for investors
- Wednesday, February 22, 5:54 PM Vivus (VVUS) shares resume trading, +90.6% after an FDA advisory panel votes to recommend Qnexa. Also with weight-loss drugs waiting for approval: ARNA +18.8%, OREX +14%.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 5 comments:
What to do now? Hold a 100% gain in anticipation of more or get out and move on to the next one?